Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, place...
Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine
About this item
Full title
Author / Creator
Publisher
Cambridge, UK: Cambridge University Press
Journal title
Language
English
Formats
Publication information
Publisher
Cambridge, UK: Cambridge University Press
Subjects
More information
Scope and Contents
Contents
There is a need for a rapid-acting, non-injection, acute treatment for agitation.
To evaluate inhaled loxapine for acute treatment of agitation in schizophrenia.
This phase III, randomised, double-blind, placebo-controlled, parallel-group study (ClinicalTrials.gov number NCT00628589) enrolled 344 individuals who received one, two or three dos...
Alternative Titles
Full title
Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_954599402
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_954599402
Other Identifiers
ISSN
0007-1250
E-ISSN
1472-1465
DOI
10.1192/bjp.bp.110.081513
